Achievements, Collaborations, Innovation Celebrated at Inaugural Women Building Bio Event
Monday, October 10, 2016
Virginia Bio, the statewide non-profit association representing the life science industry in the Commonwealth of Virginia, successfully hosted its inaugural conference Women Building Bio: The XX Factor to celebrate the role of women in the bioscience community, share strategies for driving collaboration in research and commercialization, highlight tactics for developing employees and leaders in the workplace and discuss the importance of educating and encouraging female students to participate in STEM programs.
Women Building Bio: The XX Factor, held on September 29 at the Inova Center for Personalized Health, brought together 250 leaders from enterprise life science companies and research institutions to entrepreneurs, legislators and academias. This event marked the first time women across the industry have come together from across Virginia and the BioHealth Capital region to identify needs and opportunities, make connections and continue driving excellence in bioscience.
“We are thrilled with the outcome of our first Women Building Bio conference,” said Crystal Icenhour, CEO of Aperiomics and chairman for Virginia Bio. “Women from across the region and in the industry are proving that we are leading the way on creating stronger, healthier communities due to the advancement of biosciences.”
Attendees of Women Building Bio participated in a variety of thought-provoking sessions and panels delivered by industry leaders including Todd Stottlemyer, CEO of Inova Center for Personalized Health; Rachel King, CEO GlycoMimetics; Barbara Newhouse, president and CEO of The ALS Association; Rep. Barbara Comstock; Amy Caro, sector vice president and general manager, Health Division, Northrop Grumman Information Systems; and Mindy Goldsborough, chief science and technology Officer of American Type Culture Collection.
“Women Building Bio was a success because of the extraordinary talent and resources we have in Virginia, Maryland and D.C.,” said Jeffrey Gallagher, CEO of Virginia Bio. “To see over 250 attendees embrace collaboration and innovation, regardless of their differences, to continue building the most important industry of our time, was truly inspiring.”
Virginia Bio plans on continuing highlighting the themes of innovation, celebration and collaboration at its upcoming events across the state, including at the statewide conference THRIVE 2017, on April 6 at the Hilton Virgina Beach Oceanfront.
About the Virginia Biotechnology Association
Virginia Bio is the premier statewide non-profit trade association for life sciences, promoting the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. Virginia Bio is an advocate for innovation and entrepreneurship, and for the biopharmaceutical, and other health technology industries among federal, state and local policy-makers. Virginia Bio is the official state affiliate of the Biotechnology Industry Organization (BIO), AdvaMed and the Medical Device Manufacturers Association (MDMA) and also collaborates closely with the Pharmaceutical Research and Manufacturers of America (PhRMA). To learn more, visit www.vabio.org or Follow Virginia Bio on Twitter at @VABio.
THANK YOU TO OUR SPONSORS
Women Building Bio: The XX Factor was made possible by Inova, George Mason University, Darden Executive Education, Greenberg Traurig, PhRMA, Virginia Economic Development Partnership, Squire Patton Boggs, Pfizer, Xenith, Prince William County, HHMI Janelia Research Campus, Cherry Bekaert, Merck, George Washington University, AstraZeneca/MedImmune, Silverline Communications, Loudoun Virginia Economic Development, Northrop Grumman, Illumina, New England Lab, Embody, Avison Young, Virginia Biotechnology Research Park, Euclid, Polymer Solutions and James Madison University.